EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: What's New?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|6|682-698

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.6, 2010-06, pp. : 682-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives

By Hernandez-Alcoceba Ruben  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 827-841

Informa Healthcare

Access to resources Recommend Favorite

MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside

By  

Current Medicinal Chemistry, Vol. 21, Iss. 8, 2014-01 ,pp. : 975-989

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoprevention of Cancers in Gastrointestinal Tract with Cyclooxygenase 2 Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 1, 2013-01 ,pp. : 115-125

Bentham Science Publishers

Access to resources Recommend Favorite

Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC

By  

Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. : 3894-3900

Bentham Science Publishers

Access to resources Recommend Favorite

Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract

By Ponchel G.   Montisci M.-J.   Dembri A.   Durrer C.   Duchene D.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 44, Iss. 1, 1997-07 ,pp. : 25-31

Elsevier

Access to resources Recommend Favorite